Aragon Pharmaceuticals Obtains $42,000,000 Series C Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f44304db-9839-48df-b3c0-da8dc9787003&Preview=1 - Date
3/6/2012 - Company Name
Aragon Pharmaceuticals - Mailing Address
12780 El Camino Real San Diego, CA 92130 - Company Description
Aragon Pharmaceuticals is a San Diego based biopharmaceutical company focused on developing a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. - Website
http://www.aragonpharmaceuticals.com - Transaction Type
Venture Equity - Transaction Amount
$42,000,000 - Transaction Round
Series C - Proceeds Purposes
This $42 million round of financing puts Aragon on strong footing to execute on its promising pipeline in prostate cancer and breast cancer. - M&A Terms
- Venture Investor
Topspin Partners - Venture Investor
Aisling Capital - Venture Investor
OrbiMed Advisors - Venture Investor
The Column Group
